Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Ochratoxin A: developmental and reproductive toxicity-an overview

F. Malir, V. Ostry, A. Pfohl-Leszkowicz, E. Novotna,

. 2013 ; 98 (6) : 493-502. (Clinical and molecular teratology)

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't, Review

Ochratoxin A (OTA) is nephrotoxic, hepatotoxic, reprotoxic, embryotoxic, teratogenic, neurotoxic, immunotoxic, and carcinogenic for laboratory and farm animals. Male and female reproductive health has deteriorated in many countries during the last few decades. A number of toxins in environment are suspected to affect reproductive system in male and female. OTA is one of them. OTA has been found to be teratogenic in several animal models including rat, mouse, hamster, quail, and chick, with reduced birth weight and craniofacial abnormalities being the most common signs. The presence of OTA also results in congenital defects in the fetus. Neither the potential of OTA to cause malformations in human nor its teratogenic mode of action is known. Exposure to OTA leads to increased embryo lethality manifested as resorptions or dead fetuses. The mechanism of OTA transfer across human placenta (e.g., which transporters are involved in the transfer mechanism) is not fully understood. Some of the toxic effects of OTA are potentiated by other mycotoxins or other contaminants. Therefore, OTA exposure of pregnant women should be minimized. OTA has been shown to be an endocrine disruptor and a reproductive toxicant, with abilities of altering sperm quality. Other studies have shown that OTA is a testicular toxin in animals. Thus, OTA is a biologically plausible cause of testicular cancer in man.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008415
003      
CZ-PrNML
005      
20150408095903.0
007      
ta
008      
150306s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/bdrb.21091 $2 doi
035    __
$a (PubMed)24395216
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Malir, Frantisek $u Department of Biology, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic.
245    10
$a Ochratoxin A: developmental and reproductive toxicity-an overview / $c F. Malir, V. Ostry, A. Pfohl-Leszkowicz, E. Novotna,
520    9_
$a Ochratoxin A (OTA) is nephrotoxic, hepatotoxic, reprotoxic, embryotoxic, teratogenic, neurotoxic, immunotoxic, and carcinogenic for laboratory and farm animals. Male and female reproductive health has deteriorated in many countries during the last few decades. A number of toxins in environment are suspected to affect reproductive system in male and female. OTA is one of them. OTA has been found to be teratogenic in several animal models including rat, mouse, hamster, quail, and chick, with reduced birth weight and craniofacial abnormalities being the most common signs. The presence of OTA also results in congenital defects in the fetus. Neither the potential of OTA to cause malformations in human nor its teratogenic mode of action is known. Exposure to OTA leads to increased embryo lethality manifested as resorptions or dead fetuses. The mechanism of OTA transfer across human placenta (e.g., which transporters are involved in the transfer mechanism) is not fully understood. Some of the toxic effects of OTA are potentiated by other mycotoxins or other contaminants. Therefore, OTA exposure of pregnant women should be minimized. OTA has been shown to be an endocrine disruptor and a reproductive toxicant, with abilities of altering sperm quality. Other studies have shown that OTA is a testicular toxin in animals. Thus, OTA is a biologically plausible cause of testicular cancer in man.
650    _2
$a zvířata $7 D000818
650    _2
$a blokátory kalciových kanálů $x toxicita $7 D002121
650    _2
$a karcinogeny $x toxicita $7 D002273
650    _2
$a křečci praví $7 D006224
650    _2
$a endokrinní disruptory $x toxicita $7 D052244
650    _2
$a vystavení vlivu životního prostředí $x škodlivé účinky $7 D004781
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a ochratoxiny $x toxicita $7 D009793
650    _2
$a těhotenství $7 D011247
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a rozmnožování $x účinky léků $7 D012098
650    _2
$a spermie $x abnormality $7 D013094
650    _2
$a teratogeneze $x účinky léků $7 D064793
650    _2
$a teratogeny $x toxicita $7 D013723
650    _2
$a testikulární nádory $x chemicky indukované $7 D013736
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Ostry, Vladimir
700    1_
$a Pfohl-Leszkowicz, Annie
700    1_
$a Novotna, Eva
773    0_
$w MED00007311 $t Birth defects research. Part B, Developmental and reproductive toxicology. Clinical and molecular teratology $x 1542-9741 $g Roč. 98, č. 6 (2013), s. 493-502
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24395216 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20150408100139 $b ABA008
999    __
$a ok $b bmc $g 1065688 $s 891215
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 98 $c 6 $d 493-502 $i 1542-9741 $m Birth defects research. Part B. Developmental and reproductive toxicology $n Birth Defects Res Part B Dev Reprod Toxicol $x MED00007311 $o Clinical and molecular teratology
LZP    __
$a Pubmed-20150306

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...